| |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Previous Article | Next Article ![]()
Antimicrobial Agents and Chemotherapy, November 2007, p. 4177-4180, Vol. 51, No. 11
0066-4804/07/$08.00+0 doi:10.1128/AAC.00603-07
Copyright © 2007, American Society for Microbiology. All Rights Reserved.

Department of Infectious, Parasitic, Immune-Mediated Diseases, Istituto Superiore di Sanità, Rome, Italy,1 INRA, UR1282, Infectiologie Animale et Santé Publique, IASP, Nouzilly F-37380, France,2 Centre National de Référence des Salmonella, Unité de Biodiversité des Bactéries Pathogènes Emergentes, 28 rue du Docteur Roux, 75724 Paris cedex 15, France3
Received 8 May 2007/ Returned for modification 13 July 2007/ Accepted 3 August 2007
Salmonella enterica blaCTX-M-2 and blaCTX-M-9 plasmid backbones from isolates from Belgium and France were analyzed. The blaCTX-M-2-plasmids from both human and poultry isolates were related to the IncHI2 pAPEC-O1-R plasmid, previously identified in the United States in avian Escherichia coli strains; the blaCTX-M-9 plasmids were closely related to the IncHI2 R478 plasmid.
Published ahead of print on 13 August 2007.
This article has been cited by other articles:
| Clin. Vaccine Immunol. | Clin. Microbiol. Rev. |
|---|---|
| J. Clin. Microbiol. | ALL ASM JOURNALS |